GA/HbA1c ratio is a simple and practical indicator to evaluate the risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: an observational study

Table 2 Association of GA/HbA1c ratio with MAFLD

	B statistic	OR	95% CI	P value
Model 1	−0.306	0.736	0.702–0.773	< 0.001
Model 2	−0.190	0.827	0.784–0.872	< 0.001
Model 3	−0.139	0.871	0.825–0.919	< 0.001
Model 4	−0.173	0.841	0.783–0.904	< 0.001
Model 5	−0.162	0.851	0.781–0.926	< 0.001
Model 6	−0.553	0.575	0.471–0.702	< 0.001

Model 1: unadjusted
Model 2: adjusted for age, sex, DD, smoking status, alcohol intake, obesity, and hypertension
Model 3: further adjustment for use of LLD, IIAs, metformin, and insulin sensitizers
Model 4: further adjustment for SBP, DBP, WC, WHR, and BMI
Model 5: further adjustment for TC, TG, HDL-C, LDL-C, eGFR, Cr, SUA, UAE, FCP, 2-h CP, HOMA2-IR, FPG, 2-h PPG, and CRP
Model 6: further adjustment for GA and HbA1C

ISSN: 1758-5996